NVO » Topics » Appendix 5: Condensed cash flow statement

This excerpt taken from the NVO 6-K filed Nov 1, 2007.

Appendix 5: Condensed cash flow statement

DKK million
9M 2007
9M 2006




Net profit 7,545 4,728
 
Adjustment for non-cash items 3,157 4,389
Income taxes paid and net interest received (1,492 ) (1,117 )




Cash flow before change in working capital 9,210 8,000
 
Net change in working capital (1,721 ) (621 )




Cash flow from operating activities 7,489 7,379
 
Net investments in intangible assets and long-term financial assets (126 ) (345 )
Capital expenditure for property, plant and equipment (1,549 ) (1,888 )
Net change in marketable securities (maturity exceeding three months) 3 511




Net cash used in investing activities (1,672 ) (1,722 )
 
Cash flow from financing activities (4,746 ) (4,837 )
 
NET CASH FLOW 1,071 820
 
Unrealised gain/(loss) on exchange rates and marketable securities
included in cash and cash equivalents (1 ) (16 )




Net change in cash and cash equivalents 1,070 804
 
Cash and cash equivalents at the beginning of the year 2,985 2,483




Cash and cash equivalents at the end of the period 4,055 3,287
 
Bonds with original term to maturity exceeding three months 994 999
Undrawn committed credit facilities 7,454 7,458




FINANCIAL RESOURCES AT THE END OF THE PERIOD 12,503 11,744
 
Cash flow from operating activities 7,489 7,379
+ Net cash used in investing activities (1,672 ) (1,722 )
- Net change in marketable securities (maturity exceeding three months) 3 511
FREE CASH FLOW 5,814
5,146

Stock Exchange Announcement no 29 / 2007  
Financial statement for the period 1 January 2007 to 30 September 2007
Page 1 of 19

Novo Nordisk A/S
Investor Relations
Novo Allé
2880 Bagsværd
Denmark
Telephone:
+45 4444 8888
Telefax:
+45 4444 6626
Internet:
novonordisk.com
CVR number:
24256790

 

This excerpt taken from the NVO 6-K filed Oct 30, 2006.

Appendix 6: Condensed cash flow statement

DKK million
9M 2006
 
9M 2005
 





         
Net profit 4,728   4,668  
         
Adjustment for non-cash items 4,389   3,653  
Income taxes paid and net interest received (1,117 ) (1,300 )





Cash flow before change in working capital 8,000   7,021  
         
Net change in working capital (621 ) (668 )





Cash flow from operating activities 7,379   6,353  
         
Net investments in intangible assets and long-term financial assets (345 ) (122 )
Capital expenditure for property, plant and equipment (1,888 ) (2,545 )
Net change in marketable securities (>3 months) 511   -  





Net cash used in investing activities (1,722 ) (2,667 )
         
Cash flow from financing activities (4,837 ) (4,164 )
         
NET CASH FLOW 820   (478 )
         
Unrealised gain/(loss) on exchange rates in cash and cash equivalents (16 ) 154  





Net change in cash and cash equivalents 804   (324 )
         
Cash and cash equivalents at the beginning of the year 2,483   2,963  





Cash and cash equivalents at the end of the period 3,287   2,639  
         
Bonds with original term to maturity exceeding three months 999   503  
Undrawn committed credit facilities 7,458   7,462  





FINANCIAL RESOURCES AT THE END OF THE PERIOD 11,744   10,604  
         
Cash flow from operating activities 7,379   6,353  
+ Net cash used in investing activities (1,722 ) (2,667 )
- Net change in marketable securities (maturity exceeding three months) 511   -  
FREE CASH FLOW 5,146   3,686  

Stock Exchange Announcement no 34 / 2006  
Page 17 of 17
           
Novo Nordisk A/S Novo Allé   Telephone: Internet: CVR number:
  2880 Bagsværd  
+45 4444 8888
novonordisk.com 24256790
Investor Relations Denmark   Telefax:    
     
+45 4443 6633
   

This excerpt taken from the NVO 6-K filed Apr 28, 2006.

Appendix 6: Condensed cash flow statement

DKK million
Q1 2006
 
Q1 2005
 




 
         
Net profit 1,211   1,232  
         
Adjustment for non-cash items 1,388   887  
Income taxes paid and net interest received (579 ) (558 )




 
Cash flow before change in working capital 2,020   1,561  
         
Net change in working capital 71   (218 )




 
Cash flow from operating activities 2,091   1,343  
         
Net investments in intangible assets and long-term financial assets (30 ) (6 )
Capital expenditure for property, plant and equipment (595 ) (723 )
Net change in marketable securities (>3 months) 510   2  




 
Net cash used in investing activities (115 ) (727 )
         
Cash flow from financing activities (2,286 ) (1,808 )
         
NET CASH FLOW (310 ) (1,192 )
         
Unrealised gain/(loss) on exchange rates in cash and cash equivalents (4 ) 130  




 
Net change in cash and cash equivalents (314 ) (1,062 )
         
Cash and cash equivalents at the beginning of the year 2,483   2,963  




 
Cash and cash equivalents at the end of the period 2,169   1,901  
         
Bonds with original term to maturity exceeding three months 999   507  
Undrawn committed credit facilities 7,462   6,705  




 
FINANCIAL RESOURCES AT THE END OF THE PERIOD 10,630   9,113  
         
Cash flow from operating activities 2,091   1,343  
+ Net cash used in investing activities (115 ) (727 )
- Net change in marketable securities (maturity exceeding three months) 510   2  
FREE CASH FLOW 1,466   614  

Stock Exchange Announcement No 17 / 2006
Page 17 of 17

Novo Nordisk A/S

Investor Relations
Novo Allé
2880 Bagsværd
Denmark
Telephone:
+45 4444 8888
Telefax:
+45 4443 6633
Internet:
novonordisk.com
CVR number:
24256790
 

This excerpt taken from the NVO 6-K filed Oct 28, 2005.

Appendix 6: Condensed cash flow statement

DKK million 9M 2005   9M 2004  


 
 
         
Net profit 4,668   3,551  
         
Net reversals with no effect on cash flow 3,653   4,056  
Income taxes paid and net interest received (1,300 ) (1,662 )


 
 
Cash flow before change in working capital 7,021   5,945  
         
Net change in working capital (668 ) (395 )


 
 
Cash flow from operating activities 6,353   5,550  
         
Net investments in intangible assets and long-term financial assets (122 ) (204 )
Capital expenditure for property, plant and equipment (2,545 ) (1,907 )
Net change in marketable securities (>3 months) -   1,303  


 
 
Total cash flow from investing activities (2,667 ) (808 )
         
Cash flow from financing activities (4,164 ) (2,838 )
         
NET CASH FLOW (478 ) 1,904  
         
Unrealised gain/(loss) on exchange rates in cash and cash equivalents 154   (22 )


 
 
Net change in cash and cash equivalents (324 ) 1,882  
         
Cash and cash equivalents at the beginning of the year 2,963   841  


 
 
Cash and cash equivalents at the end of the period 2,639   2,723  
         
Bonds with original term to maturity exceeding three months 503   504  
Undrawn committed credit facilities 7,462   6,697  


 
 
FINANCIAL RESOURCES AT THE END OF THE PERIOD 10,604   9,924  
         
FREE CASH FLOW* 3,686   3,439  

*) Cash flow from operating activities + Cash flow from investing activities - Net change in marketable securities (>3 months)

Stock Exchange Announcement No 25 / 2005 Page 18 of 18

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki